In a footnote of his opinion, Judge Joshua Roberts wrote, “A more cynical view of the circumstances is that plaintiffs’ ...

The FDA has mandated updated safety labeling for two respiratory syncytial virus vaccines, Pfizer's Abrysvo and GlaxoSmithKline's Arexvy, following the identification of an increased risk of ...

The FDA has required the manufacturers of the RSV Vaccines Abrysvo and Arexvy to add a new warning to their labels about the ...

Saisei Ventures, a leading investment firm focused on advancing Japanese biotechnology and therapeutic innovations, announced today that Dr. Sven Kili has been appointed partner at the firm. Dr. Kili ...

Abingdon-based Oxford Instruments told investors that experienced executive Paul Fry will be appointed as its chief financial ...

Ramos, previously Pfizer's senior vice president and global head of BioTherapeutics R&D, has been appointed to the board of ...

This latest investment, which brings OXcan’s total funding to date to $16.7 million, will be used to develop and globally ...

Read about vaccine sales, Akums and more in the latest Market Talks covering Health Care.

Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...

British drug maker GSK plc (GSK, GSK.L) announced Friday that the US Food and Drug Administration has accepted for review the ...

As for GBS itself, this neurological ailment can be severe, attacking nerves and warranting hospitalisation for weeks or ...

On Tuesday, January 7, the FDA announced it would now be requiring GSK and Pfizer’s RSV vaccines to hold warnings of a risk ...